• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Leonard H. Sigal, John M. Zahradnik, +16 authors Stephen E. Malawista
  • Medicine
  • The New England journal of medicine
  • 1998 (First Published: 23 July 1998)
  • BACKGROUND Lyme disease is a multisystem inflammatory disease caused by infection with the tick-borne spirochete Borrelia burgdorferi and is the most common vector-borne infection in the UnitedContinue Reading
  • Porter W. Anderson, Michael E. Pichichero, +7 authors Ronald Eby
  • Biology, Medicine
  • Journal of immunology
  • 1989 (First Published: 1 April 1989)
  • Vaccines consisting of oligosaccharide (OS) derived from Haemophilus influenzae type b capsular polysaccharide and conjugated to carrier proteins had been shown capable of eliciting memory-typeContinue Reading
  • David I Bernstein, John M. Zahradnik, C J DeAngelis, James D. Cherry
  • Medicine
  • American journal of diseases of children
  • 1982 (First Published: 1 June 1982)
  • Clinical reactions and hemagglutinating-inhibiting (HAI) antibody responses to recent whole-virus and split-product influenza vaccines were studied in 168 children and young adults. The subjectsContinue Reading
  • Carl E. Frasch, John M. Zahradnik, Lai Y Wang, Louis F. Mocca, Chi Ming Tsai
  • Medicine
  • The Journal of infectious diseases
  • 1988 (First Published: 1 October 1988)
  • A group B Neisseria meningitidis serotype protein vaccine was studied clinically in adults. The vaccine comprised lipopolysaccharide-depleted outer membrane vesicles from a serotype 2b strain,Continue Reading
  • C. J. Luke, Margaret A. Marshall, John M. Zahradnik, Mike Bybel, B E Menefee, Alan G Barbour
  • Medicine
  • The Journal of infectious diseases
  • 2000 (First Published: 1 March 2000)
  • Serial serum samples from a 2-year human trial of outer surface protein (Osp) A vaccine were analyzed by Borrelia burgdorferi growth-inhibition assay (GIA) and anti-OspA ELISA to assess the antibodyContinue Reading
  • David I Bernstein, Mark R Schleiss, +8 authors Stanley A. Plotkin
  • Medicine
  • The Journal of infectious diseases
  • 2002 (First Published: 1 March 2002)
  • Development of a vaccine for prevention of congenital cytomegalovirus (CMV) disease is a priority. This study evaluated a "prime-boost" strategy by comparing the safety and immunogenicity of 3 dosesContinue Reading